Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 5Unknown 4Completed 3Not yet recruiting 2Terminated 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Pain 1Neoplasms 1Disease 1Chronic Pain 1Cancer Pain 1COVID-19 1Adenoma 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × Diagnostic Tests, Routine × Clear all
NCT04421625 2025-12-30

PAPESCO-19

Institut Cancerologie de l'Ouest

Phase NA Completed
1,102 enrolled 4 charts

COVID-19

NCT03981809 2023-08-22

PainsCan

Universitaire Ziekenhuizen KU Leuven

Completed
92 enrolled

Cancer Pain, Neoplasms, Pain, Chronic Pain

NCT00633620 2008-03-12

BECOP-2

Charite University, Berlin, Germany

Phase NA Completed
1,250 enrolled

Adenoma, Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡